Otorhinolaryngologic Diseases: Clinical Trials

7,568 trials for Otorhinolaryngologic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3992 completed, 1296 unknown, 863 recruiting, 407 terminated. 3047 Not applicable, 1241 Phase 2, 846 Phase 3, 499 Phase 1, 429 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3047Completed 1579, Unknown 501, Recruiting 366, Not yet recruiting 194, Terminated 152, Withdrawn 126, Active not recruiting 77, Enrolling by invitation 42, Suspended 10
Phase 21241Completed 619, Unknown 210, Recruiting 142, Terminated 95, Active not recruiting 64, Not yet recruiting 63, Withdrawn 40, Suspended 5, Enrolling by invitation 3
Phase 3846Completed 488, Unknown 112, Recruiting 88, Terminated 64, Active not recruiting 42, Not yet recruiting 28, Withdrawn 21, Enrolling by invitation 2, Suspended 1
Phase 1499Completed 285, Unknown 59, Terminated 44, Recruiting 43, Withdrawn 25, Not yet recruiting 22, Active not recruiting 19, Suspended 2
Phase 4429Completed 278, Unknown 57, Terminated 29, Recruiting 23, Withdrawn 21, Not yet recruiting 12, Active not recruiting 9
Early Phase 184Completed 34, Unknown 19, Recruiting 12, Terminated 9, Not yet recruiting 4, Withdrawn 4, Enrolling by invitation 1, Suspended 1

Follow Otorhinolaryngologic Diseases: new trials by email Literature Review of Otorhinolaryngologic Diseases trials Research Report on Otorhinolaryngologic Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
Personalized ART, Non-personalized ART - Empty Nose Syndrome, Nasal Obstruction
Not applicableNot yet recruitingStanford University402028-07-012025-10-10
EFFECT OF AYURVEDA TREATMENT IN ALLERGIC RHINITIS
AYURVEDA treatment protocol, Control(Citrizine 10mg) - Allergic Rhinitis (AR)
Not applicableNot yet recruitingAmrita Vishwa Vidyapeetham1042028-06-302026-06-04
AI-Enabled Mobile App for Safe Eating in Older Adults With Dysphagia
AI-Enabled Mobile Application plus Standard Care, Standard Dysphagia Education - Deglutition Disorders, Dysphagia
Not applicableNot yet recruitingKAM Chi Shan Anna3322028-01-012026-09-23
Role of Exposure in Hyperacusis
Psychoeducation - Hyperacusis
Not applicableNot yet recruitingUniversity Hospital, Antwerp52027-12-072026-04-29
A Personalized Voice Restoration Device for Patients With Laryngectomy
Surface Electromyography - Dysphonia, Aphonia
Not applicableNot yet recruitingWeill Medical College of Cornell University1002027-12-012026-06-16
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
Otic neural progenitors, cochlear implantation - Sensorineural Hearing Loss, Presbyacusis
Phase 1 / Phase 2Not yet recruitingRinri Therapeutics202027-09-012026-10-01
Hearing Loss and Brain Health Study
Over-The-Counter (OTC) hearing aid - Hearing Loss, Adult-Onset, Dementia
Not applicableNot yet recruitingUniversity of Southern California402027-07-012026-05-08
Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial
Expiratory muscle strength training (EMST), Standard of Care Dysphagia Treatment, Intensive Dysphagia Treatment - Dysphagia, Critical Illness
Not applicableNot yet recruitingVanderbilt University Medical Center1202027-07-012026-10-14
Parent Implemented Oral Nutrition, Eating, and Esophageal Reflexes Reintegration Protocol: RCT
PIONEER Protocol - Deglutition Disorders in Infants, Chronic Tube Feeding in Hospitalized Infants
Not applicableNot yet recruitingNationwide Children's Hospital1302027-07-012026-08-28
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
The Microtable® Stereotactic System - Hearing Loss, Cochlear
Not applicableNot yet recruitingMedical University of South Carolina122027-07-012026-06-18
Cochlear Implantation and Social Outcomes
Cochlear implant - Hearing Loss, Bilateral Sensorineural
Not yet recruitingUniversity of Southern California402027-07-012026-06-22
Intervention for Hearing Health Among Native Americans
Talking Circle, Diabetes prevention program & delayed TC - Noise-Induced Hearing Loss
Not applicableNot yet recruitingUniversity of California, San Francisco4002027-04-012026-08-21
Swallowing Impairments in ICU Survivors and Community-Dwelling Adults
Dysphagia, Healthy Aging
WithdrawnVanderbilt University Medical Center2027-04-012026-06-02
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
From Early Music Audiometry to Tone Audiograms
Soundfield Behavioral Audiometry - Hearing Loss, Audiometric Tests
Not yet recruitingGuy's and St Thomas' NHS Foundation Trust1002027-03-012026-07-24
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)
Prednisone, Ajovy, Manual Therapy - Cranial Nerve Injury, Oropharyngeal Cancer
Phase 1Not yet recruitingM.D. Anderson Cancer Center482027-03-012026-09-21
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-09-03
Auditory-Cognitive Optimization Care Program for Older Adults With Hearing Loss and Cognitive Impairment
Auditory-Cognitive Optimization Care Program (A-COP), Hearing Management and Newspaper-Reading Activities - Hearing Loss, Cognitive Impairment
Not applicableNot yet recruitingTaipei Medical University762027-02-012026-10-13
A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus
paliroden (CIL001), Placebo - Tinnitus, Bilateral, Cochlear Synaptopathy
Phase 1 / Phase 2Not yet recruitingCilcare SAS602027-01-012026-09-17

Showing 20 of 7568. Sign in to see all of them.

Narrower conditions

Deglutition Disorders (832)  ·  Hearing Loss (764)  ·  Rhinitis, Allergic (679)  ·  Nasopharyngeal Carcinoma (645)  ·  Tinnitus (427)  ·  Rhinitis, Allergic, Seasonal (384)  ·  Oropharyngeal Neoplasms (367)  ·  Hearing Loss, Sensorineural (336)  ·  Head and Neck Neoplasms (310)  ·  Laryngeal Neoplasms (256)  ·  Pharyngitis (226)  ·  Nasopharyngeal Neoplasms (224)  ·  Otitis Media (219)  ·  Asthma (213)  ·  Rhinitis (212)

Broader conditions

Pathological Conditions, Signs and Symptoms (3178)  ·  Respiratory Tract Diseases (3155)  ·  Nervous System Diseases (2859)  ·  Signs and Symptoms (2712)  ·  Ear Diseases (2703)  ·  Neurologic Manifestations (2487)  ·  Pharyngeal Diseases (2341)  ·  Nose Diseases (1914)  ·  Sensation Disorders (1860)  ·  Hearing Disorders (1700)  ·  Stomatognathic Diseases (1624)  ·  Neoplasms by Site (1587)  ·  Neoplasms (1571)  ·  Otorhinolaryngologic Neoplasms (1441)

Interventions

Cisplatin (257)  ·  Radiotherapy, Intensity-Modulated (112)  ·  Gemcitabine (99)  ·  Radiotherapy (91)  ·  Hearing Aids (81)  ·  Mometasone Furoate (80)  ·  Docetaxel (72)  ·  Fluticasone (67)  ·  Fluorouracil (64)  ·  Sodium Chloride (59)  ·  Dexamethasone (56)  ·  toripalimab (51)  ·  Cochlear Implants (49)  ·  montelukast (46)  ·  Carboplatin (45)

Sponsors

Sun Yat-sen University (215)  ·  GlaxoSmithKline (112)  ·  Cochlear (84)  ·  Sonova AG (81)  ·  Organon and Co (77)  ·  Assiut University (64)  ·  National Cancer Institute (NCI) (54)  ·  Washington University School of Medicine (52)  ·  Assistance Publique - Hôpitaux de Paris (48)  ·  Eye & ENT Hospital of Fudan University (44)  ·  Johns Hopkins University (43)  ·  Oticon Medical (43)  ·  Mayo Clinic (42)  ·  M.D. Anderson Cancer Center (40)  ·  NYU Langone Health (37)

Countries

United States (2314)  ·  China (867)  ·  France (502)  ·  Canada (380)  ·  Germany (320)  ·  United Kingdom (277)  ·  Turkey (Türkiye) (268)  ·  Spain (184)  ·  Belgium (180)  ·  Taiwan (161)  ·  Italy (156)  ·  Switzerland (151)  ·  South Korea (149)  ·  Egypt (132)  ·  Australia (123)

Top investigators

Nieto Luis, Master (21)  ·  Luo Zhang (15)  ·  Carl LeBel, PhD (14)  ·  Jun Ma, M.D. (14)  ·  Jay F Piccirillo, MD (11)  ·  Ming-Yuan Chen, MD,PhD (11)

Results publications

PMID 31150573, PMID 33710614, PMID 19001265, PMID 27158989, PMID 30207593, PMID 32926419, PMID 24184147, PMID 27686945, PMID 28837405, PMID 29584545, PMID 34341578, PMID 17270511, PMID 18331513, PMID 19140539, PMID 21439168, PMID 21441148, PMID 22464647, PMID 23374268, PMID 24035151, PMID 24836393, PMID 25133431, PMID 25685162, PMID 26171894, PMID 28602936, PMID 29656145, PMID 30213452, PMID 31178151, PMID 31723056, PMID 33492986, PMID 33548517, PMID 35240053, PMID 35724253, PMID 35997729, PMID 36746459, PMID 37185596, PMID 37951571, PMID 38197558, PMID 38507662, PMID 39035788, PMID 39970442, PMID 42572144, PMID 10734019, PMID 11297958, PMID 15385385, PMID 15817806, PMID 16137276, PMID 17021840, PMID 17030153, PMID 17135456, PMID 17917842

NIH funding

2023 (17), 2015 (16), 2018 (13), 2019 (13), 2025 (10), 2008 (9), 2009 (9), 2014 (9), 2016 (9), 2017 (9), U10CA180868 (9), P50DC007667 (7), P30CA138292 (6), U10CA180820 (6), 2005 (5)